Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Executive Function in Learning in Children With Attention Deficit Hyperactivity Disorder (ADHD) Receiving Medical Treatment Alone Compared to Children Receiving Additional Treatment to Improve Learning Strategies

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2012 by Hillel Yaffe Medical Center.
Recruitment status was  Not yet recruiting
Information provided by (Responsible Party):
Hillel Yaffe Medical Center Identifier:
First received: February 8, 2012
Last updated: February 9, 2012
Last verified: February 2012
The purpose of this study is to determine whether there is a difference in executive function in learning in children with ADHD receiving medical treatment alone to the executive function in children receiving, in addition to medical treatment in learning strategies.


Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Further study details as provided by Hillel Yaffe Medical Center:

Primary Outcome Measures:
  • Level of Executive Functioning [ Time Frame: One year ] [ Designated as safety issue: No ]
    Brief Behavior Rating Inventory of Executive Function will be administered

Estimated Enrollment: 30
Study Start Date: March 2012
Estimated Study Completion Date: March 2013
Estimated Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)
Combined Therapy
ADHD Medication and Learning Strategies Treatment
ADHD Medication Treatment
Control group


Ages Eligible for Study:   6 Years to 15 Years   (Child)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Children with ADHD treated in the Institute for Child Development at Hillel Yaffe Medical Center

Inclusion Criteria:

  • Normal development for age
  • ADHD

Exclusion Criteria:

  • Low compliance
  • Developmental delay
  • Chronic disease
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01531127

Contact: Muhammad Mahajnah, MD, PhD 972-506246959

Hillel Yaffe Medical Center
Hadera, Israel, 38100
Sponsors and Collaborators
Hillel Yaffe Medical Center
  More Information

Responsible Party: Hillel Yaffe Medical Center Identifier: NCT01531127     History of Changes
Other Study ID Numbers: 0014-12-HYMC 
Study First Received: February 8, 2012
Last Updated: February 9, 2012
Health Authority: Israel: Ministry of Health

Additional relevant MeSH terms:
Attention Deficit Disorder with Hyperactivity
Attention Deficit and Disruptive Behavior Disorders
Neurodevelopmental Disorders
Mental Disorders processed this record on October 21, 2016